Practically the best ’omics

We offer affordable metabolomics and scalable remote blood collection.

Products for research

Choose us for fast, proven, no-nonsense data.

CoreMetabolomics

Affordable high-throughput metabolomics from blood or urine.

RemoteOmics

Reliable self-collected blood samples take multi-omics research everywhere.

Nightingale Health’s metabolomic research service enables reproducible and cost-effective measurement of lipids, inflammation, dietary intake, insulin sensitivity, and much more.

Our biomarkers are associated with diverse aspects of human health, from cardiometabolic disease to kidney and liver function to dementia and mental health. They also reflect the exposome, including smoking, and diet, providing foundational data for every analysis in your study.

If you genotype each sample, you should also have a metabolic snapshot as part of the basic core data. Take your research to the next level with metabolic insights across human health.

Nightingale Health brings metabolomics to the scale of the world’s largest biobanks and cohorts.

Our research service provides the only platform for comprehensive metabolic profiling for whole cohorts. Nightingale Health's technology is the only omics technology that has been measured across all 500,000 participants in the UK Biobank and 200,000 participants in the Estonian Biobank.

We are proud to have partnered with these world-leading medical research studies and that our data are available to qualified researchers to amplify and replicate new research findings and increase impact.

You can also explore Nightingale Biomarker-Disease Atlas of biobank associations in the UK Biobank.

Explore Biomarker-Disease Atlas

Meet us at upcoming events

AHA Scientific Sessions

16.11.–18.11.2024

Chicago, Illinois, USA

UK Biobank Scientific Conference

10.12.2024

London, UK

Women's Health: Genes, Data and Advancing Approaches

27.01.–29.01.2025

Cambridge, UK

See all events

Why Nightingale Health?

"The cost difference between this panel and measuring standard lipids and glucose, when considering all of the additional information provided, for me, makes a clear argument for using Nightingale's platform."

Professor Deborah Lawlor

MRC Integrative Epidemiology Unit University of Bristol

”I have worked with Nightingale's NMR platform for more than a decade. It has proven to be a great platform, that we have extended to multiple population cohorts, and almost 100,000 samples. The team are great to work with, and the platform has proven itself to deliver high quality, highly reproducible results that have advanced our clinical and molecular epidemiological research.”

John Chambers

Professor of Cardiovascular Epidemiology, London, UK and Singapore

"My research groups have been working with Nightingale's team for several years. The team is easy to get in touch with, they are extremely helpful and the service is superb. Nightingale's platform makes metabolomics studies cost-effective when focusing upon biomarkers and predictors of major non-communicable disease like type 2 diabetes. I am convinced that this is an excellent way to gain valuable insights into disease pathophysiology."

Professor Johan G. Eriksson

NUS Yong Loo Lin School of Medicine and Executive director SICS, A*STAR

“Because Nightingale's assay is designed to provide informative and reliable lipidomic/metabolomic measurements at scale, it has been adopted by several major cohorts globally, including those led from our institution, helping to yield valuable insights about the predictors and determinants of important conditions.”

Professor John Danesh

Cambridge University

New research insights from our blog

Data